This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
